
1. clin liver dis. 2016 nov;20(4):703-720. doi: 10.1016/j.cld.2016.06.007. epub 2016
aug 9.

hepatitis b hepatocellular carcinoma.

hemming aw(1), berumen j(2), mekeel k(2).

author information: 
(1)division transplantation hepatobiliary surgery, department surgery, 
university california, san diego, 9300 campus point drive, # 7745 la jolla, ca
92037-1300, usa. electronic address: ahemming@ucsd.edu.
(2)division transplantation hepatobiliary surgery, department surgery, 
university california, san diego, 9300 campus point drive, # 7745 la jolla, ca
92037-1300, usa.

hepatocellular carcinoma (hcc) one leading causes cancer death
worldwide, incidence increasing last decade largely in
parallel incidence duration exposure hepatitis b c. the
widespread implementation hepatitis b vaccine, hepatitis b antivirals, the
introduction direct antiviral therapies hepatitis c virus may a
substantial impact reducing incidence hcc. report reviews risk
factors underlying mechanisms associated development hcc in
hepatitis b, along advances diagnosis, imaging, management of
hcc.

copyright Â© 2016 elsevier inc. rights reserved.

doi: 10.1016/j.cld.2016.06.007 
pmid: 27742009  [indexed medline]

